BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24908177)

  • 1. [Hypofractionated stereotactic radiotherapy of bone metastases].
    Pichon B; Thillays F; Bourgier C; Mahé MA; Supiot S
    Cancer Radiother; 2014; 18(4):342-9. PubMed ID: 24908177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiotherapy of bone metastases].
    Thureau S; Vieillard MH; Supiot S; Lagrange JL
    Cancer Radiother; 2016 Sep; 20 Suppl():S227-34. PubMed ID: 27523421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypofractionated radiotherapy in prostate cancer].
    Supiot S; Créhange G; Latorzeff I; Pommier P; Paumier A; Rio E; Delaroche G; Guérif S; Catton C; Martin J; Lisbona A
    Cancer Radiother; 2013 Oct; 17(5-6):349-54. PubMed ID: 23973460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypofractionated stereotactic body radiation therapy for adrenal metastases].
    Dupic G; Biau J; Bellière-Calandry A; Lapeyre M
    Cancer Radiother; 2017 Aug; 21(5):404-410. PubMed ID: 28684242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiotherapy of bone metastases: Which fractionations?].
    Thureau S; Leysalle A; Faivre JC; Lagrange JL
    Cancer Radiother; 2015 Oct; 19(6-7):437-41. PubMed ID: 26321686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in radiation oncology for metastatic bone disease].
    Thariat J; Fric D; Kerr C; Leysalle A; Angellier G; Dejean C; Tuillier T; Bensadoun RJ; Lagrange JL
    Bull Cancer; 2013 Nov; 100(11):1187-97. PubMed ID: 24172705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues].
    de Crevoisier R; Castelli J; Guérif S; Pommier P; Créhange G; Chauvet B; Lagrange JL
    Cancer Radiother; 2014 Oct; 18(5-6):369-78. PubMed ID: 25199865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stereotactic body radiation therapy for spinal metastases].
    Pasquier D; Martinage G; Mirabel X; Lacornerie T; Makhloufi S; Faivre JC; Thureau S; Lartigau É
    Cancer Radiother; 2016 Oct; 20(6-7):500-7. PubMed ID: 27614511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?].
    Royer P; Salleron J; Vogin G; Taillandier L; Clément-Duchêne C; Klein O; Faivre JC; Peiffert D; Bernier V
    Cancer Radiother; 2017 Dec; 21(8):731-740. PubMed ID: 28711413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiotherapy of bone metastases in France: A descriptive monocentric retrospective study].
    Le Fèvre C; Antoni D; Thiéry A; Keller A; Truntzer P; Vigneron C; Clavier JB; Guihard S; Pop M; Schumacher C; Salze P; Noël G
    Cancer Radiother; 2018 Apr; 22(2):148-162. PubMed ID: 29602695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stereotactic body radiotherapy of oligometastases: Main pending trials and to come in France].
    Giraud P; Tournat H; Kreps S; Bibault JE; Dautruche A; Fabiano E; Feutren T; Durdux C
    Cancer Radiother; 2019 Oct; 23(6-7):496-499. PubMed ID: 31471251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stereotactic body radiation therapy for spine bone oligometastatic disease].
    Thureau S; Rogé M; Marchesi V; Hadj Henni A; Faivre JC
    Cancer Radiother; 2021 Dec; 25(8):830-836. PubMed ID: 34716092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for spinal and bone metastases.
    Bhattacharya IS; Hoskin PJ
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):298-306. PubMed ID: 25687175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade.
    Milano MT; Katz AW; Zhang H; Huggins CF; Aujla KS; Okunieff P
    Radiother Oncol; 2019 Feb; 131():45-51. PubMed ID: 30773186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy of bone metastases.
    Thureau S; Supiot S; Jouglar E; Rogé M; Lebret L; Hadj Henni A; Beldjoudi G; Lagrange JL; Faivre JC
    Cancer Radiother; 2022; 26(1-2):368-376. PubMed ID: 34955420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review.
    Matsushita H; Jingu K; Umezawa R; Yamamoto T; Ishikawa Y; Takahashi N; Katagiri Y; Kadoya N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818803597. PubMed ID: 30352542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Delineation of organs at risk and dose constraints].
    Noël G; Antoni D; Barillot I; Chauvet B
    Cancer Radiother; 2016 Sep; 20 Suppl():S36-60. PubMed ID: 27516050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reirradiation of Pediatric Tumors Using Hypofractionated Stereotactic Radiotherapy.
    Gultekin M; Cengiz M; Sezen D; Zorlu F; Yildiz F; Yazici G; Hurmuz P; Ozyigit G; Akyol F; Gurkaynak M
    Technol Cancer Res Treat; 2017 Apr; 16(2):195-202. PubMed ID: 27352857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiotherapy for intrathoracic metastases].
    Giraud P; Lacornerie T; Mornex F
    Cancer Radiother; 2016 Sep; 20 Suppl():S157-60. PubMed ID: 27523413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.